WO2004080993A1 - プロアントシアニジン高含有物の製造方法 - Google Patents
プロアントシアニジン高含有物の製造方法 Download PDFInfo
- Publication number
- WO2004080993A1 WO2004080993A1 PCT/JP2003/002877 JP0302877W WO2004080993A1 WO 2004080993 A1 WO2004080993 A1 WO 2004080993A1 JP 0302877 W JP0302877 W JP 0302877W WO 2004080993 A1 WO2004080993 A1 WO 2004080993A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- proanthocyanidin
- extract
- extraction
- weight
- opc
- Prior art date
Links
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 title claims abstract description 49
- 229920001991 Proanthocyanidin Polymers 0.000 title claims abstract description 49
- 238000000034 method Methods 0.000 title claims description 32
- 239000000463 material Substances 0.000 title abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 33
- 150000003839 salts Chemical class 0.000 claims abstract description 28
- 239000003463 adsorbent Substances 0.000 claims abstract description 24
- 229910052751 metal Inorganic materials 0.000 claims abstract description 17
- 239000002184 metal Substances 0.000 claims abstract description 17
- 238000000605 extraction Methods 0.000 claims description 32
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 20
- 235000005487 catechin Nutrition 0.000 claims description 20
- 239000000057 synthetic resin Substances 0.000 claims description 20
- 229920003002 synthetic resin Polymers 0.000 claims description 20
- 150000001765 catechin Chemical class 0.000 claims description 18
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 238000003825 pressing Methods 0.000 claims description 2
- 238000003809 water extraction Methods 0.000 claims description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 claims 1
- 230000001766 physiological effect Effects 0.000 abstract description 5
- 229920002770 condensed tannin Polymers 0.000 description 88
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 40
- 239000000243 solution Substances 0.000 description 34
- 241000196324 Embryophyta Species 0.000 description 30
- 239000000126 substance Substances 0.000 description 27
- 229920005989 resin Polymers 0.000 description 20
- 239000011347 resin Substances 0.000 description 20
- 239000002904 solvent Substances 0.000 description 18
- 239000007788 liquid Substances 0.000 description 15
- 239000003960 organic solvent Substances 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 125000003118 aryl group Chemical group 0.000 description 12
- 238000001914 filtration Methods 0.000 description 11
- 238000006116 polymerization reaction Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 239000012530 fluid Substances 0.000 description 9
- 229940106587 pine bark extract Drugs 0.000 description 9
- 235000020741 pine bark extract Nutrition 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 229930014669 anthocyanidin Natural products 0.000 description 7
- 235000008758 anthocyanidins Nutrition 0.000 description 7
- 239000012046 mixed solvent Substances 0.000 description 7
- 150000008442 polyphenolic compounds Chemical class 0.000 description 7
- 235000013824 polyphenols Nutrition 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 150000001453 anthocyanidins Chemical class 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- -1 halide salts Chemical class 0.000 description 4
- 235000010204 pine bark Nutrition 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 238000000194 supercritical-fluid extraction Methods 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 235000013616 tea Nutrition 0.000 description 4
- 235000017060 Arachis glabrata Nutrition 0.000 description 3
- 244000105624 Arachis hypogaea Species 0.000 description 3
- 235000010777 Arachis hypogaea Nutrition 0.000 description 3
- 235000018262 Arachis monticola Nutrition 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229920002101 Chitin Polymers 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 240000006365 Vitis vinifera Species 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 3
- 239000003456 ion exchange resin Substances 0.000 description 3
- 229920003303 ion-exchange polymer Polymers 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 235000020232 peanut Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- 239000004278 EU approved seasoning Substances 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 244000077923 Vaccinium vitis idaea Species 0.000 description 2
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 239000003957 anion exchange resin Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 150000000017 (+)-catechin Chemical class 0.000 description 1
- 229930013884 (+)-gallocatechin Natural products 0.000 description 1
- 235000007243 (+)-gallocatechin Nutrition 0.000 description 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HVVPYFQMCGANJX-UHFFFAOYSA-N 2-methylprop-2-enyl prop-2-enoate Chemical compound CC(=C)COC(=O)C=C HVVPYFQMCGANJX-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- UCDHTHQUBPQDNU-UHFFFAOYSA-N C(CCC)C1=C(C=CC=C1)CCCC.C=CC1=CC=CC=C1 Chemical compound C(CCC)C1=C(C=CC=C1)CCCC.C=CC1=CC=CC=C1 UCDHTHQUBPQDNU-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 241000331120 Krameria cistoidea Species 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241001495449 Robinia pseudoacacia Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000543810 Sasa veitchii Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 159000000021 acetate salts Chemical class 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004523 agglutinating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 229910052790 beryllium Inorganic materials 0.000 description 1
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000003842 bromide salts Chemical class 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000005323 carbonate salts Chemical class 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 229940023913 cation exchange resins Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- QFLMUASKTWGRQE-JNIIMKSASA-N cinnamtannin A2 Chemical compound C1([C@@H]2[C@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C2=C3O[C@@H]([C@H](O)[C@H](C3=C(O)C=C2O)C2=C(O)C=C(O)C3=C2O[C@@H]([C@H](O)[C@H]3C=2C(O)=CC(O)=C3C[C@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)C=2C=C(O)C(O)=CC=2)C=2C=C(O)C(O)=CC=2)=CC=C(O)C(O)=C1 QFLMUASKTWGRQE-JNIIMKSASA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940045731 elderberry fruit Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229910052730 francium Inorganic materials 0.000 description 1
- KLMCZVJOEAUDNE-UHFFFAOYSA-N francium atom Chemical compound [Fr] KLMCZVJOEAUDNE-UHFFFAOYSA-N 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-M gallate Chemical compound OC1=CC(C([O-])=O)=CC(O)=C1O LNTHITQWFMADLM-UHFFFAOYSA-M 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- SWHAQEYMVUEVNF-UHFFFAOYSA-N magnesium potassium Chemical compound [Mg].[K] SWHAQEYMVUEVNF-UHFFFAOYSA-N 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 239000000113 methacrylic resin Substances 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- YPVZJXMTXCOTJN-UHFFFAOYSA-N pelargonidin chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 YPVZJXMTXCOTJN-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000012643 polycondensation polymerization Methods 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229910052705 radium Inorganic materials 0.000 description 1
- HCWPIIXVSYCSAN-UHFFFAOYSA-N radium atom Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- CBXWGGFGZDVPNV-UHFFFAOYSA-N so4-so4 Chemical compound OS(O)(=O)=O.OS(O)(=O)=O CBXWGGFGZDVPNV-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- SDKPSXWGRWWLKR-UHFFFAOYSA-M sodium;9,10-dioxoanthracene-1-sulfonate Chemical compound [Na+].O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2S(=O)(=O)[O-] SDKPSXWGRWWLKR-UHFFFAOYSA-M 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 150000008054 sulfonate salts Chemical class 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
- C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
Definitions
- the present invention relates to a method for efficiently producing a proanthocyanidin-containing substance containing a large amount of OPC having high physiological activity.
- Proanthocyanidins are polymerized or condensed tannins present in various plants, and are formed by condensation or polymerization (hereinafter, referred to as condensation polymerization) using flavan-1-ol or flavan-1,4-diol as a structural unit. It is a group of bound compounds. These are given their names because they produce anthocyanidins such as cyanidin, delphinidin and pelargonidin by acid treatment.
- proanthocyanins having a low degree of polymerization are suitably used.
- a polycondensate having a degree of polymerization of 2 to 30 (2 to 30 mer) is preferable, a polycondensate having a degree of polymerization of 2 to 10 (2 to 10 mer) is more preferable, and a degree of polymerization of 2 to 30 is preferred.
- Condensed polymers of (4) to (4 to 4) are more preferably used.
- condensed polymers of proanthocyanidins a condensed polymer having a degree of polymerization of 2 to 4 containing flavan-1-3-ol-Z or flavan-1,3,4-diol as a constitutional unit, OPC (oligomeric proanthocyanidin);
- Proanthocyanidins a type of polyphenol, are potent antioxidants produced by plants and are concentrated in plant leaves, bark, fruit bark or seed parts.
- Proanthocyanidins, especially OPC specifically It is found in dough seeds, pine bark, peanut skin, ginkgo biloba, false acacia fruit and lingonberry.
- OPCs are also known to be present in cola nuts in West Africa, the roots of ratania in Peru, and green tea in Japan. OPC is a substance that cannot be produced in the human body.
- OPC In addition to its antioxidant effect, OPC also has the effect of suppressing bacterial growth in the oral cavity and reducing plaque (gum); the effect of restoring the elasticity of blood vessels; the lipoproteins in blood are damaged by active oxygen Effect of preventing injured fat from agglutinating on the inner wall of blood vessels and adhering cholesterol; effect of regenerating vitamin E decomposed by active oxygen; as an enhancer of vitamin E It is known to have effects and the like.
- tannin which is a polymer of flavan-1-ol and / or flavan-1,3-diol, and chitin, chitosan, and derivatives thereof are used in staphylococcus aureus, salmonella, typhoid, cholera, and the like. Its antibacterial and bactericidal effects are remarkable. In particular, it has been reported that MRSA (methicillin-resistant staphylococci), which has been talked about because most antibiotics do not work, is also effective.
- MRSA methicillin-resistant staphylococci
- Proanthocyanidins are generally obtained by extraction from plants.
- the solvent used for the extraction include water; organic solvents such as methanol, ethanol, acetone, hexane, and ethyl acetate; and mixtures thereof (Japanese Patent Application Laid-Open No. 11-180488).
- simply extracting with a solvent results in low recovery and low purity of oral anthocyanidins. Therefore, in order to use it as a raw material for health foods, cosmetics, and pharmaceuticals, further concentration and purification steps are required to increase the purity, which is costly and time consuming.
- Japanese Patent Application Laid-Open No. Hei 5-279694 and Japanese Patent Application Laid-Open No. Hei 6-56689 describe a method for recovering polyphenols containing proanthocyanin.
- polyphenols are adsorbed to chitin, and polyphenols are The chitin adsorbed with phenols is used as a polyphenol product.
- the adsorbed and absorbed polyphenols are polyphenols with a high degree of polymerization, and the content of the above-mentioned highly active dimer to tetramer OPC is extremely low. Low activity.
- the present inventors have intensively studied a method for efficiently obtaining a bronthocyanidin-containing substance having a useful physiological activity and having a high OPC content.
- proanthocyanidins containing a large amount of highly bioactive OPCs are extracted by extracting proanthocyanidins from plants, adding salts to the resulting extracts, and treating them with a synthetic resin-based adsorbent.
- the present invention was completed by finding that a product can be obtained efficiently.
- the present invention provides a method for producing a proanthocyanidin-containing substance
- the extraction is a hot water extraction.
- the metal salt is a monovalent gold salt.
- the present invention also provides a proanthocyanidin-containing substance containing an oligomeric proanthocyanidin (OPC) and a phytotechin, which is contained in the port anthocyanidin-containing substance in terms of a dry weight in terms of an oligomeric substance. It contains more than 20% by weight of proanthocyanin (OPC) and 5 to 15% by weight of techin.
- OPC oligomeric proanthocyanidin
- the present invention also provides a method for producing a proanthocyanidin-containing product containing 20% by weight or more of oligomeric proanthocyanin in terms of dry weight, comprising the steps of: It includes a step of treating with a salt of a monovalent or divalent metal.
- the plant used in the present invention is a plant containing proanthocyanin, and its type is not particularly limited. Bark of cedar, cypress, pine, etc., rich in proanthocyanidins; grape, blueberry, strawberry, apogado, -secacia, lingonberry, elderberry fruit, peel or seed; barley; wheat; soybeans; black soybeans; cacao Red beans; Conker shells; Peanut shells; Ginkgo biloba leaves; Tea leaves and tea extracts; Sorghum cane; Apple fruit; Kumazasa; Fucoidan; , Peru-Latania) roots.
- pine bark, grape seeds and pericarp, peanut skins and the like are particularly preferably used.
- Step of obtaining extract or juice from plant by extraction or pressing proanthocyanidin is extracted from the plant or juice is obtained from the plant.
- the plant is preferably crushed to an appropriate size from the viewpoint of extraction efficiency, and the surface area per volume is increased.
- the crushing method is not particularly limited. For example, a crushed material processed by a cutter, a slicer, or the like; a crushed material processed by a mixer, a juicer, a blender, a masscopper, or the like may be used.
- the size of the crushed material or the powder frame is a small piece of 0.1 to 10 cm, preferably 0:! To 5 cm.
- Water or an organic solvent such as ethanol, methanol or ethyl acetate may be added during the crushing to increase the crushing efficiency.
- Water or an organic solvent is used as an extraction solvent.
- the organic solvent include methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, acetone, hexane, cyclohexane, propylene glycol, aqueous ethanol, aqueous propylene glycol, and ethyl methyl ketone.
- Glycerin methinole acetate, ethyl acetate, ethynole ether, dichloromethane, edible fats and oils, 1,1,1,2-tetrafluoroethane, and 1,1,2-trichloroethene.
- a mixed solvent of water and an organic solvent is also preferably used. These organic solvents may be used alone or in combination. Water is preferably used from the viewpoint of waste liquid treatment at the time of production and from the viewpoint of adding metal or metal salt to be described later.
- the amount of the extraction solvent to be added to the plant can be set in consideration of the desired proanthocyanin concentration and the extraction efficiency.
- the weight ratio of plant: water is 1: 5 to 1: 100, preferably 1:10 to 1:50.
- the amount of extraction solvent to be added may be adjusted in consideration of the amount used for mashing.
- extract with hot water at 50 to 120 ° C, preferably 7 ° to 100 ° C. Plant You may add hot water to the plant, then add water to the plant and heat it.
- the extraction time is generally from 10 minutes to 24 hours, but can be appropriately determined depending on the extraction temperature.
- an extraction method using an organic solvent warm extraction or supercritical fluid extraction may be used.
- a method of adding a heated solvent to a plant or a method of adding a solvent to a plant and heating is used.
- a 5: 1 volume water-ethanol mixture solvent with a water: ethanol ratio of 1: 1 by weight to the ground plant is used as an extraction solvent and refluxed at 70-75 ° C. And stirring for 3 hours.
- the extraction temperature must be set to a value equal to or lower than the boiling point of the organic solvent.
- the supercritical fluid extraction method is a method of extracting a target component using a supercritical fluid, which is a fluid that has exceeded the critical point (critical temperature, critical pressure) of a substance's gas-liquid.
- a supercritical fluid a fluid that has exceeded the critical point (critical temperature, critical pressure) of a substance's gas-liquid.
- the supercritical fluid carbon dioxide, ethylene, propane, nitrous oxide (laugh gas) and the like are used, and carbon dioxide is preferably used.
- the supercritical fluid extraction method comprises an extraction step of extracting a target component with a supercritical fluid, and a separation step of separating the target component from a supercritical fluid. In the separation process, either extraction separation by pressure change, extraction separation by temperature change, or extraction separation using adsorbent / absorbent may be performed.
- supercritical fluid extraction by an entrainer addition method may be performed.
- ethanol, propanol, n-hexane, acetone, toluene, other aliphatic lower alcohols, aliphatic hydrocarbons, aromatic hydrocarbons, or ketones are added to a supercritical fluid.
- any of a batch type, a semi-continuous type, and a continuous type may be used.
- the plant When juice is obtained from the plant, the plant is directly squeezed or, after being appropriately cut or crushed, squeezed.
- This method is suitably adopted when a plant having a high water content is used.
- a plant having a high water content For example, in the case of grape berries, squeezing produces a juice containing pulp anthocyanidins.
- a crushed plant body containing solid matter derived from the plant body obtained by crushing the plant body (for example, the above-mentioned crushed grape fruit) is also used in the same manner as the squeezed juice.
- a crushed plant containing a solid content of is also included in the juice.
- extracts a monovalent or divalent metal salt
- extract a monovalent or divalent metal salt
- extracts a monovalent or divalent metal salt
- proanthocyanidins having a high degree of polymerization are precipitated and removed as precipitates.
- organic solvent it is preferable to remove the organic solvent by dialysis, concentration under reduced pressure, or the like, and replace the water with water. By substituting with water, ionization of the salt solution in the solution is improved, and proanthocyanin having a high degree of polymerization can be efficiently removed.
- the temperature of the extract when adding the salts is not particularly limited. However, when the extraction is performed under a heating condition, it is preferable to add the salts after the temperature of the extract has dropped to 1 to 40 ° C.
- the salts to be added to the extract or the like may be those that ionize in the solution. However, weak to strongly alkaline salts that affect the stability of proanthocyanin are not suitable.
- Monovalent metals are the alkali metals lithium, sodium, potassium, rubidium, cesium, and francium. Are preferably used as salts.
- the divalent metals are beryllium, magnesium, and alkaline earth metals (calcium, strontium, barium, and radium), and these metal salts are used.
- the salts include halide salts (such as chloride salts and bromide salts), phosphate salts, carbonate salts, and organic acid salts (such as carboxylate salts such as acetate salts and sulfonate salts).
- halide salts such as chloride salts and bromide salts
- phosphate salts such as calcium salts and calcium phosphate
- organic acid salts such as carboxylate salts such as acetate salts and sulfonate salts.
- Specific examples thereof include sodium salt sodium, sodium salt sodium, sodium phosphate, potassium phosphate, sodium acetate and the like.
- a monovalent alkali metal salt is used because purification efficiency can be increased without adding an auxiliary agent for stabilizing proanthocyanidin (for example, ascorbic acid or a pH adjusting agent). .
- the above salts are added to the extract or the like so that the total weight of the obtained extract or the like is 10% by weight to a saturated amount, preferably 20% by weight to a saturated amount. After adding the salts, the mixture is allowed to stand at 1 ° C to 40 ° C for 30 minutes to 48 hours to precipitate a precipitate.
- a divalent metal for example, potassium magnesium
- a divalent metal When a divalent metal is used, it has a strong adsorptivity to proanthocyanidin and its pH is likely to be 6 or more, so that it binds to not only proanthocyanidin having a high degree of polymerization but also OPC to form a precipitate.
- a solution having a concentration of 2 to 3 times the predetermined final concentration adjust the pH to 4 to 6 in advance, and then add this to an extract or the like.
- the time for depositing the precipitate may be 48 hours or more, but it is preferable to shift to the next step before the OPC is automatically oxidized and the reddish brown is turned into a dark brown.
- Methods for removing insolubles include methods commonly used by those skilled in the art, for example, filtration and centrifugation.
- Filtration is preferably used in terms of processing time. Filtration may preferably be performed at 1-40 ° C. The lower the temperature, the more Proanthocyanidins having a high degree of polymerization can be removed, and the reaction is preferably performed at 30 ° C or lower, more preferably at 25 ° C or lower.
- This filtration treatment may be performed before adding the salt, but in this case, it is necessary to perform the filtration after the addition of the salt in order to remove the precipitate.
- the content of proanthocyanidin of pentamer or more in the crude anthocyanidin-containing liquid obtained here is ⁇ or less, preferably 1 Z 3 or less, more preferably less than the case where no salts were added. Is less than 1/5. Further, in the method of the present invention, it is not necessary to remove salts dissolved in the crude proanthocyanidin-containing solution before the next step of treating with the synthetic resin adsorbent. it can.
- Step of treating the crude proanthocyanidin-containing liquid with a synthetic resin-based adsorbent treating the obtained crude proanthocyanidin-containing liquid with a synthetic resin-based adsorbent, the sugar-containing and organic acids Contaminants are removed and further purified.
- the crude proanthocyanin-containing liquid is brought into contact with a synthetic resin-based adsorbent, and the proanthocyanidins are adsorbed on the synthetic resin-based adsorbent, and then eluted with a predetermined solvent, so that more OPC is obtained.
- a proanthocyanidin-containing substance can be obtained.
- Examples of the synthetic resin-based adsorbent used for the above purification include an organic resin, an ion exchange resin, silica gel, and reversed-phase silica gel.
- an aromatic resin such as a styrene-dibutylbenzene-based resin, an methallyl acrylate-based resin, and an aliphatic attarylonitrile resin
- it is an aromatic resin.
- the aromatic resin include an aromatic resin having a hydrophobic substituent, an unsubstituted aromatic resin, and an aromatic resin obtained by subjecting a non-substituted group to a special treatment. An aromatic resin which has been subjected to a special treatment is more preferable. These resins are preferably porous.
- Such synthetic resins are commercially available, for example: Examples: Acrylic methacrylic resin: Diaion (registered trademark) HP 1MG, HP 2MG (all manufactured by Mitsubishi Chemical Corporation); Aromatic resin: SP-900 (Mitsubishi Chemical Corporation) , Amberlite (registered trademark) XAD-2, XAD-4, XAD-16, XAD-2000 (all manufactured by Organo Co., Ltd.); As an aromatic resin having a hydrophobic substituent, DIAION (registered trademark) ) SP-205, SP-206, SP-207, HP-2MG, EX-0021 (Mitsubishi Chemical Corporation), Amberlite (registered trademark) XAD-7, XAD-8 (Mall, Inc.) Unsubstituted aromatic resins include DIAION (registered trademark) HP-10, HP-20, HP-21, HP-30, HP-40, HP-50 (all Mitsubishi Chemical Corporation) SP-82 is an aromatic resin obtained by specially treating unsubstituted groups.
- any of a cation exchange resin and an anion exchange resin can be used.
- Commercially available cation exchange resins include, for example, resins having a sulfonate group as a functional group, such as Amberlite (registered trademark) CG-4000, CG-5000, CG-6000, CG-8000, IR — 116, IR—118, IR—120 B, IR—122, IR—124, XT-1007, XT-1009, XT-1002 (all manufactured by Olgano Corporation).
- the weakly basic anion exchange resin examples include, for example, resins having a quaternary amine as a functional group, OPT I PORE-XUS 40285.00, OPT I PORE-XUS 40390.00 (all manufactured by D-Chemical Co., Ltd.) ) And the like. Dissolution when using ion exchange resin
- the solvent is preferably water, the column temperature is 10 to 120 ° C., and the inside of the column is preferably at normal pressure or pressurized state.
- the amount of the synthetic resin-based adsorbent may be appropriately set depending on the type of the solvent, the type of the synthetic resin-based adsorbent, and the like. For example, it is preferable to use 0.01 to 5 times the weight of the synthetic resin adsorbent based on the dry weight of the solution.
- a synthetic resin-based adsorbent is packed in a column, and the proanthocyanin-containing substance is passed through the column. Then, 5 to 10 times the weight of water relative to the weight of the synthetic resin adsorbent is passed. As a result, saccharides and organic acids as impurities are removed. Then, the proanthocyanin is dissolved with an appropriate solvent.
- the solvent include water, methanol, ethanol, ethyl acetate, chloroform, and a mixed solvent thereof.
- a mixed solvent of water and ethanol is used.
- the mixing ratio of water and ethanol depends on the synthetic resin adsorbent used.
- synthetic resin adsorbent used for example, in the case of an acrylic metharyl resin such as Diaion HP-20, it is 5 to 50% by weight, preferably 10 to 10% by weight.
- An aqueous solution of about 40% by weight of ethanol is used.
- the proanthocyanidin-containing substance may be treated with the synthetic adsorbent by a batch method.
- the synthetic adsorbent is added to the crude proanthocyanin solution at the same weight ratio as the above column method, and the mixture is brought into contact for 1 to 3 hours with stirring, and then the adsorbent is recovered by filtration or centrifugation.
- the collected synthetic adsorbent is further washed with the same solvent as in the column method described above, the adsorbed broantocyanidin is stirred with the extraction solvent for 1 to 3 hours, and then OPC is removed by filtration or centrifugation. A more proanthocyanin-containing material is obtained.
- proanthocyanidin-containing substance having an extremely high OPC content is obtained. can get.
- the proanthocyanidin-containing substance also includes a concentrate, a diluent, a powder, and the like obtained by a method usually used by those skilled in the art.
- the resulting proanthocyanin-containing material may further contain techinols in terms of dry weight, preferably 5 to 15% by weight, more preferably 10 to 15% by weight.
- Catechins are poorly water-soluble by themselves and have low physiological activity, but when combined with catechins, OPCs increase the water solubility of catechins and activate the action of catechins Has properties. Therefore, proanthocyanidin-containing materials containing OPCs and catechins are particularly useful:
- Catechins are a general term for polyhydroxyflavan-1-ol.
- the power techins include (+) one strength techin, (-1) eppicatechin, (+)-gallocatechin, (_) epigallocatechin, epigallocatechin gallate, and epiki tekin gallate.
- it includes afzelequin derived from natural products, and 3-galloyl derivatives of (+)-catechin or gallocatechin.
- catechins include carcinogenesis suppression, arteriosclerosis prevention, fat metabolism abnormality suppression, blood pressure increase suppression, platelet aggregation suppression, antiallergic, antiviral, antibacterial, caries prevention, bad breath It has a preventive effect, a normalizing effect on the intestinal microflora, a scavenging effect of active oxygen and free radicals, an antioxidant effect, and an antidiabetic effect for suppressing an increase in blood sugar.
- the proanthocyanidin-containing substance produced by the above method can be concentrated to produce a food material.
- Various methods such as membrane concentration, heat concentration, vacuum (reduced pressure) concentration, and freeze concentration are used for concentration.
- these proanthocyanidin-containing substances are sterilized. And save. Sterilization is performed by a method commonly used by those skilled in the art, such as airflow sterilization, high-pressure sterilization, and heat sterilization.
- these proanthocyanin-containing substances may be sterilized, concentrated, dried, and powdered. Drying is performed by a method commonly used by those skilled in the art. Of these, freeze drying, vacuum drying, and spray drying are preferred.
- the proanthocyanidin-containing material thus obtained can be used as a raw material for food, cosmetics, or pharmaceuticals.
- the resulting proanthocyanin-containing substance can also be used as a drink, a gelled food or the like.
- the proanthocyanin-containing material is not only used for eating and drinking as it is, but also mixed with excipients, bulking agents, binders, thickeners, emulsifiers, fragrances, food additives, seasonings, etc.
- it can be formed into granules, tablets and the like.
- it can be mixed with royal jelly, vitamins, protein, calcium, chitosan, lecithin, caffeine, etc., and then tasted with a sugar solution and seasonings.
- They are also made into capsules, such as hard capsules and soft capsules, pills, or tea bags. These may be eaten as they are, or may be dissolved in water, hot water, milk, or the like, depending on their shape or preference.
- the ingredients may be leached before drinking.
- the amount of pentamer or more proanthocyanidin contained in the obtained crude proanthocyanidin-containing solution A was compared with that of the pine bark extract before the salt treatment as follows.
- the TLC deployment conditions and the detection method are as follows.
- the amount of proanthocyanidin was determined by comparing the degree of coloring of proanthocyanidins of pentamer or more (R f value: 0.1 or less). Table 1 shows the results.
- Example 2 In the same manner as in Example 1 except that the final concentration of sodium chloride to be added was 25% by weight, 90 mL of crude proanthocyanin-containing solution B was obtained, and the amount of proanthocyanin was determined by TLC. Was. The results are shown in Table 1.
- a crude proanthocyanin-containing solution C of 92 OmL was obtained in the same manner as in Example 1 except that the final concentration of salt chickadium to be added was 10% by weight, and the amount of proanthocyanin was determined by TLC. Was. The results are shown in Table 1.
- Example 4 The crude proanthocyanin-containing solution A was further purified as follows. First, 90 OmL of crude proanthocyanidin-containing solution A was passed through a column filled with 25 g of an aromatic synthetic resin (Diaion HP-20: manufactured by Mitsubishi Chemical Corporation), and proanthocyanidin was added. Was adsorbed to the column. The column was washed with 1 L of purified water, and then eluted from the column with a 15% (V / V) mixed solvent of ethanol and water to obtain 20 OmL of solution A containing purified proanthocyanidin. The dry weight was measured.
- an aromatic synthetic resin Diaion HP-20: manufactured by Mitsubishi Chemical Corporation
- the obtained purified proanthocyanin-containing solution A is mixed with a component containing OPC, a component containing catechins, a component other than catechins, and other components including a polymer (hereinafter, referred to as other components). Then, it was separated as follows. First, 25 mL of Sephadex LH-20 (manufactured by Pharmacia Biotech) swollen with water was packed in a 15 ⁇ 30 OmL column, and washed with 25 mL of ethanol. Dissolve 100 mg of the above dry powder in 2 mL of ethanol, pass it through a column and allow it to adsorb, then gradient with 100-80% (V / V) ethanol / water mixed solvent.
- TLC TLC was performed on the fractions other than OPC using catechin as an index (R f value: 0.8), and the fraction was separated into a fraction containing phytotechins and a fraction of other components. Released.
- the TLC development conditions and detection method were the same as described above.
- the fraction containing phytotechins was further separated into catechins and components other than phytotechins as follows. First, the fraction containing phytotechins was freeze-dried, the obtained powder was dissolved in 3 mL of water, and this was swelled with water to obtain 2 OmL of MCI gel (manufactured by Mitsubishi Eigaku Corporation). The liquid was adsorbed by passing through a column packed in a 15 X 30 OmL column. After the column was washed with water, the column was eluted with a mixed solvent of 10 to 100% (V / V) ethanol / aqueous solution, and fractionated in 10 mL portions. After the elution was completed, catechins in each fraction were detected by TLC using catechin as an index, and separated into tetekins fractions and fractions of components other than tetekins.
- MCI gel manufactured by Mitsubishi Eigaku Corporation
- the OPC fraction, phytotechin fraction, fractions other than catechins, and fractions of other components obtained as described above were each powdered by freeze-drying, and the dry weight was measured.
- the sum of the OPC fraction, the phytotechin fraction, the fractions of components other than catechins, and the fractions of other components is 99.2 to 100 mg per 100 mg of dry powder of purified proanthocyanidin-containing solution A 99.6 mg, almost all of which had been recovered.
- Table 2 shows the dry weight of the purified proanthocyanidin-containing solution A, and the content and content of OPC, catechins, and proanthocyanidins of pentamer or more in terms of dry weight.
- the purified proanthocyanidin-containing liquids B and C were obtained in the same manner as in Example 4 above, and the crude protoanthocyanidin-containing liquids B and C were separated into fractions. The results are shown in Table 2.
- each of the purified proanthocyanin-containing liquids A to C had an OPC content of 20% by weight or more on a dry weight basis.
- proanthocyanidin-containing solution A obtained by adding sodium chloride to the pine bark extract to a final concentration of 20% by weight or more, contains 30% by weight or more of OPC.
- a monovalent alkali metal proanthocyanidins having a high OPC content can be obtained from plants without adding an auxiliary agent for stabilizing the proanthocyanidins. It was found that it could be extracted.
- the method of the present invention by simply treating an extract from a plant with a synthetic resin-based adsorbent, it is possible to easily obtain a proanthocyanidin-containing substance containing a high proportion of OPC having high physiological activity. it can.
- This protocyanidin-containing substance having a high OPC content also contains phytotechins. Therefore, OPC has a synergistic effect of activating the action of catechins.
- These proanthocyanidin-containing substances are effective in improving vascular enhancement, hypertension, coldness, etc., and are very useful as raw materials for producing foods, cosmetics, and pharmaceuticals.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pyrane Compounds (AREA)
Abstract
Description
Claims
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2003/002877 WO2004080993A1 (ja) | 2003-03-11 | 2003-03-11 | プロアントシアニジン高含有物の製造方法 |
AU2003211600A AU2003211600A1 (en) | 2003-03-11 | 2003-03-11 | Process for producing proanthocyanidin-rich material |
AU2003235464A AU2003235464A1 (en) | 2003-03-11 | 2003-06-11 | Process for producing proanthocyanidin enriched product |
PCT/JP2003/007446 WO2004080994A1 (ja) | 2003-03-11 | 2003-06-11 | プロアントシアニジン高含有物の製造方法 |
PCT/JP2003/010032 WO2004080992A1 (ja) | 2003-03-11 | 2003-08-06 | プロアントシアニジン高含有物の製造方法 |
AU2003254835A AU2003254835A1 (en) | 2003-03-11 | 2003-08-06 | Process for producing proanthocyanin-rich material |
CA002517668A CA2517668A1 (en) | 2003-03-11 | 2004-03-10 | Process for producing proanthocyanin-rich material |
PCT/JP2004/003158 WO2004080995A1 (ja) | 2003-03-11 | 2004-03-10 | プロアントシアニジン高含有物の製造方法 |
JP2005503555A JP3808494B2 (ja) | 2003-03-11 | 2004-03-10 | プロアントシアニジン高含有物の製造方法 |
EP04719137A EP1602653A1 (en) | 2003-03-11 | 2004-03-10 | Process for producing proanthocyanin-rich material |
US10/548,415 US20060177525A1 (en) | 2003-03-11 | 2004-03-10 | Process for producing proanthocyanin-rich material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2003/002877 WO2004080993A1 (ja) | 2003-03-11 | 2003-03-11 | プロアントシアニジン高含有物の製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004080993A1 true WO2004080993A1 (ja) | 2004-09-23 |
Family
ID=32983436
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/002877 WO2004080993A1 (ja) | 2003-03-11 | 2003-03-11 | プロアントシアニジン高含有物の製造方法 |
PCT/JP2003/007446 WO2004080994A1 (ja) | 2003-03-11 | 2003-06-11 | プロアントシアニジン高含有物の製造方法 |
PCT/JP2003/010032 WO2004080992A1 (ja) | 2003-03-11 | 2003-08-06 | プロアントシアニジン高含有物の製造方法 |
PCT/JP2004/003158 WO2004080995A1 (ja) | 2003-03-11 | 2004-03-10 | プロアントシアニジン高含有物の製造方法 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/007446 WO2004080994A1 (ja) | 2003-03-11 | 2003-06-11 | プロアントシアニジン高含有物の製造方法 |
PCT/JP2003/010032 WO2004080992A1 (ja) | 2003-03-11 | 2003-08-06 | プロアントシアニジン高含有物の製造方法 |
PCT/JP2004/003158 WO2004080995A1 (ja) | 2003-03-11 | 2004-03-10 | プロアントシアニジン高含有物の製造方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20060177525A1 (ja) |
EP (1) | EP1602653A1 (ja) |
JP (1) | JP3808494B2 (ja) |
AU (3) | AU2003211600A1 (ja) |
CA (1) | CA2517668A1 (ja) |
WO (4) | WO2004080993A1 (ja) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050142233A1 (en) * | 2002-03-27 | 2005-06-30 | Hououdou Co., Ltd. | Compositions for treating and/or preventing pollinosis |
US20100004329A1 (en) * | 2004-12-14 | 2010-01-07 | Toyo Shinyaku Co., Ltd. | Alcohol metabolism enhancer and alcoholic beverage |
EP1888090B1 (en) | 2005-05-02 | 2017-11-22 | 4Life Patents, LLC | Transfer factor preparations and associated methods |
US9028882B2 (en) | 2005-05-02 | 2015-05-12 | 4Life Patents, Llc | Nutraceutical gels |
WO2006117168A2 (de) * | 2005-05-03 | 2006-11-09 | Dr. Willmar Schwabe Gmbh & Co. Kg | Verfahren zur herstellung von ginkgoextrakten mit vermindertem gehalt an unpolaren pflanzeninhaltsstoffen und umweltbedingten unpolaren fremdstoffen |
CN101287482B (zh) * | 2005-09-28 | 2014-06-04 | 星座公司 | 葡萄提取物、其膳食补充剂及其方法 |
EP1913951B1 (fr) * | 2006-10-17 | 2019-04-03 | Nexira | Procédé d'extraction de substances polyphénoliques et leurs utilisations |
PT2033641E (pt) * | 2007-08-01 | 2012-04-10 | Ferlux | Processo de preparação de extractos ricos em proantocianidinas |
JP5588351B2 (ja) * | 2007-12-21 | 2014-09-10 | フィンツェルベルグ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニエ コマンデット ゲゼルシャフト | ローズヒップ抽出物含有調剤 |
FR2927811B1 (fr) * | 2008-02-27 | 2010-09-10 | Unither Dev | Colorant pharmaceutique extrait de cranberry concentre en proanthocyanidines a. |
MX2010011922A (es) * | 2008-05-06 | 2011-03-02 | Finzelberg Gmbh & Co Kg Star | Extracto de cistus que contiene ingredientes vegetales secundarios enriquecidos. |
US10398366B2 (en) | 2010-07-01 | 2019-09-03 | Nokia Technologies Oy | Responding to changes in emotional condition of a user |
WO2015055889A1 (en) * | 2013-10-18 | 2015-04-23 | Mika Tapio Reijonen | A method for the production of pine bark extract to be used as a pharmaceutical, herbal or cosmetic ingredient, by using a magnesium compound |
CN108392540B (zh) * | 2018-04-16 | 2021-04-06 | 河北医科大学 | 一种洋金花总生物碱的提取方法 |
US20240251826A1 (en) * | 2018-10-02 | 2024-08-01 | West Invest Sa | Process for producing purified pac's and sugar from fruit juice, and compositions comprising same |
CN111830147A (zh) * | 2020-06-09 | 2020-10-27 | 贵州茅台酒股份有限公司 | 一种高粱中单宁浓度的检测方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4698360A (en) * | 1985-04-09 | 1987-10-06 | Societe Civile D'investigations Pharmacologiques D'aquitaine | Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof |
JPS6442479A (en) * | 1987-08-10 | 1989-02-14 | Kikkoman Corp | Production of procyanidin |
JPH03200781A (ja) * | 1989-12-28 | 1991-09-02 | Kikkoman Corp | プロアントシアニジンの製造法 |
US5484594A (en) * | 1988-06-28 | 1996-01-16 | Tecnofarmaci S.P.A. | Process for preparing grapeseed extracts enriched in procyanidol oligomers |
WO1998009526A1 (en) * | 1996-09-04 | 1998-03-12 | Biotics Research Corporation | Antioxidant derived from lentil and its preparation and uses |
JP2001106634A (ja) * | 1999-10-08 | 2001-04-17 | Nobutaka Suzuki | 月経困難症、子宮内膜症の治療薬 |
EP1180516A1 (en) * | 1999-04-23 | 2002-02-20 | Kyowa Hakko Kogyo Co., Ltd. | Methods for purifying proanthocyanidin oligomers |
JP2003095964A (ja) * | 2001-09-21 | 2003-04-03 | Toyo Shinyaku:Kk | 抗ストレス剤 |
JP2003095965A (ja) * | 2001-09-27 | 2003-04-03 | Toyo Shinyaku:Kk | 高血圧症の予防・治療剤 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1219732B (it) * | 1988-06-28 | 1990-05-24 | Tecnofarmaci Spa | Frazioni oligomeriche procianidoliche,loro procedimento di preparazione e composizioni farmaceutiche che le contengono |
US5484592A (en) * | 1989-03-23 | 1996-01-16 | Stitching Centraal Diergeneeskundig Instituut | Peptide, immunogenic composition and vaccine or medicinal preparation: a method of immunising a mammal against LHRH, and a method of improving the meat quality of pigs |
JP2857646B2 (ja) * | 1990-11-26 | 1999-02-17 | キッコーマン株式会社 | 抗変異原性剤 |
JPH07196645A (ja) * | 1993-12-28 | 1995-08-01 | Yokohama Yushi Kogyo Kk | ポリフェノール類の抽出方法及び該方法により得られる抽出液と抽出物 |
AU727283B2 (en) * | 1996-05-23 | 2000-12-07 | Enzo Nutraceuticals Limited | Process for extraction of proanthocyanidins from botanical material |
JPH1059846A (ja) * | 1996-06-10 | 1998-03-03 | Kikkoman Corp | 白内障の予防または治療薬剤 |
JPH10218769A (ja) * | 1997-02-06 | 1998-08-18 | Kikkoman Corp | 抗潰瘍剤 |
US5912363A (en) * | 1997-08-29 | 1999-06-15 | Interhealth Nutraceuticals | Method for extraction of proanthocyanidins from plant material |
JP2002097187A (ja) * | 2000-09-21 | 2002-04-02 | Usaien Seiyaku Kk | ポリフェノール類の抽出方法および該方法の行程で得られるポリフェノール金属塩 |
-
2003
- 2003-03-11 AU AU2003211600A patent/AU2003211600A1/en not_active Abandoned
- 2003-03-11 WO PCT/JP2003/002877 patent/WO2004080993A1/ja not_active Application Discontinuation
- 2003-06-11 AU AU2003235464A patent/AU2003235464A1/en not_active Abandoned
- 2003-06-11 WO PCT/JP2003/007446 patent/WO2004080994A1/ja not_active Application Discontinuation
- 2003-08-06 WO PCT/JP2003/010032 patent/WO2004080992A1/ja not_active Application Discontinuation
- 2003-08-06 AU AU2003254835A patent/AU2003254835A1/en not_active Abandoned
-
2004
- 2004-03-10 EP EP04719137A patent/EP1602653A1/en not_active Withdrawn
- 2004-03-10 CA CA002517668A patent/CA2517668A1/en not_active Abandoned
- 2004-03-10 WO PCT/JP2004/003158 patent/WO2004080995A1/ja not_active Application Discontinuation
- 2004-03-10 JP JP2005503555A patent/JP3808494B2/ja not_active Expired - Lifetime
- 2004-03-10 US US10/548,415 patent/US20060177525A1/en not_active Abandoned
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4698360A (en) * | 1985-04-09 | 1987-10-06 | Societe Civile D'investigations Pharmacologiques D'aquitaine | Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof |
US4698360B1 (en) * | 1985-04-09 | 1997-11-04 | D Investigations Pharmacologiq | Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof |
JPS6442479A (en) * | 1987-08-10 | 1989-02-14 | Kikkoman Corp | Production of procyanidin |
US5484594A (en) * | 1988-06-28 | 1996-01-16 | Tecnofarmaci S.P.A. | Process for preparing grapeseed extracts enriched in procyanidol oligomers |
JPH03200781A (ja) * | 1989-12-28 | 1991-09-02 | Kikkoman Corp | プロアントシアニジンの製造法 |
WO1998009526A1 (en) * | 1996-09-04 | 1998-03-12 | Biotics Research Corporation | Antioxidant derived from lentil and its preparation and uses |
EP1180516A1 (en) * | 1999-04-23 | 2002-02-20 | Kyowa Hakko Kogyo Co., Ltd. | Methods for purifying proanthocyanidin oligomers |
JP2001106634A (ja) * | 1999-10-08 | 2001-04-17 | Nobutaka Suzuki | 月経困難症、子宮内膜症の治療薬 |
JP2003095964A (ja) * | 2001-09-21 | 2003-04-03 | Toyo Shinyaku:Kk | 抗ストレス剤 |
JP2003095965A (ja) * | 2001-09-27 | 2003-04-03 | Toyo Shinyaku:Kk | 高血圧症の予防・治療剤 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2004080995A1 (ja) | 2006-06-08 |
AU2003254835A1 (en) | 2004-09-30 |
CA2517668A1 (en) | 2004-09-23 |
AU2003211600A1 (en) | 2004-09-30 |
EP1602653A1 (en) | 2005-12-07 |
US20060177525A1 (en) | 2006-08-10 |
JP3808494B2 (ja) | 2006-08-09 |
AU2003235464A1 (en) | 2004-09-30 |
WO2004080994A1 (ja) | 2004-09-23 |
WO2004080995A1 (ja) | 2004-09-23 |
WO2004080992A1 (ja) | 2004-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004080993A1 (ja) | プロアントシアニジン高含有物の製造方法 | |
JP2002097187A (ja) | ポリフェノール類の抽出方法および該方法の行程で得られるポリフェノール金属塩 | |
JP2003325135A (ja) | 健康食品 | |
JPWO2003091237A1 (ja) | プロアントシアニジン高含有物の製造方法 | |
US7863466B2 (en) | Method of producing proanthocyanidin-containing material | |
JP2001299305A (ja) | 活性酸素消去用組成物およびその製造法 | |
JP2003334022A (ja) | 持久力向上用食品組成物 | |
JP3689413B2 (ja) | フラバン化合物含有組成物 | |
JP2005097324A (ja) | 健康食品および健康飲料 | |
JP5398101B2 (ja) | スフィンゴ脂質を有効成分とする樹皮抽出物成分の吸収促進剤 | |
JP2003192603A (ja) | 抗ガン剤および健康食品 | |
WO2006115123A1 (ja) | ウィルス不活化剤 | |
JP2005047818A (ja) | 健康食品および健康飲料 | |
JP4400712B2 (ja) | 抗酸化能増強食品 | |
JP2003095965A (ja) | 高血圧症の予防・治療剤 | |
US20080249163A1 (en) | Process For Producing Product Containing Proanthocyanidin in High Proportion | |
KR20060069885A (ko) | 프로안토시아니딘 고함유물의 제조방법 | |
JP5681895B2 (ja) | 食品組成物 | |
JP2005013208A (ja) | 健康食品および健康飲料 | |
JP4977024B2 (ja) | プロアントシアニジン含有物の製造方法 | |
WO2005087758A1 (ja) | プロアントシアニジン水可溶性結合体およびそれを含有する組成物 | |
WO2005070443A1 (ja) | 樹皮抽出物 | |
JP3819413B1 (ja) | 苦味または渋味を有する食品原料を含有する食品 | |
KR20180134657A (ko) | 미성숙 감으로부터 폴리페놀을 추출하는 방법 | |
JP2005013213A (ja) | 健康食品および健康飲料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |